The WoundReference Digital Formulary Module is available in all WoundReference plans, including the Free Basic Plan (see Plans). We have more than 100 providers caring for over 3,000 patients in Long Term Care, Acute Care, Skilled Nursing facilities, and in-home health. 43fi)CU;AQTQhdiqe\[$ Mf8Oa*C[&1d9J^. <]/Prev 376811/XRefStm 1838>> Antibacterial preparations only used topically, 13.10.1.2. NHS Fife: Area Drugs and Therapeutics Committee, Paediatric Primary Care Antibiotic Guidelines, Guidance on the Management of Proven or Suspected Staph. Standardization ensures only proven cost-effective products are used. endobj The information that you provide will be reviewed by the Wound Formulary Group and will be taken into consideration when the formulary is revised and . %PDF-1.5 % 0000010187 00000 n Clinician preferences and usage patterns can help you determine baseline usage and costs before implementation of a formulary, and can provide ideas of what products clinicians might be more inclined to accept as being part of the Institutions formulary. By having products that are clinically proven and cost-effective in the formulary, ad-hoc dressing orders will be can be decreased. Back to Gloucestershire Hospitals NHS Foundation Trust website, https://ccglive.glos.nhs.uk/intranet/index.php/ccg-strategy/medicines-management/formularies/glos-dressing-formulary, Copyright Gloucestershire Hospitals 2023. endobj How to Apply Unna Boot - Tips, Techniques & Reimbursement | HBOT for Carbon Monoxide Poisoning - What's New? 0000008106 00000 n Topical local anaesthetics and antipruretics, 13.4.1 Topical corticosteroids with antimicrobials, 13.5 Preparations for eczema and psoriasis, 13.9 Shampoos and other preparations for scalp and hair conditions, 13.10.1.1. Have you had your annual medication review? 0000000016 00000 n Scottish Wound Assessment and Action Guide (SWAAG) This guide is to aid wound assessment and management, and should be used in line with local policy/guidelines. WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care. | HBOT Patient Educationy - Sep 12, 2019, Investigational/Off-Label HBOT Indications | Peer-reviewed Diabetes Foot Ulcer Patient Education in English and Spanisy - Sep 5, 2019, Connecting with Patients: Peer-reviewed Wound Care and HBOT Patient Education in English and Spanish - Aug 29, 2019, 5 Digital Tools for Patient Education in Wound Care and HBOT | Telehealth Updatesh - Aug 22, 2019, When and How to Dismiss a Patient from a Wound and Hyperbaric Center | HBOT and Congestive Heart Failure - Aug 15, 2019, Mastering Debridement in Wound Management | Creating and Maintaining Safety in Hyperbaric Facilitiese - Aug 9, 2019, Simplifying Wound Care and HBOT Product Choices | Radiation-Induced Cutaneous Damage Updates - Aug 2, 2019. PDF NHS Greater Glasgow and Clyde Wound Formulary - GGC Medicines Scottish Wound Assessment and Action Guide: February 2021 (PDF, 1204K), Pressure ulcer prevalence survey checklist, Pressure Ulcer prevalence count checklist, Adapted Glamorgan Pressure Ulcer Risk Assessment Scale - Suitable for use from Birth-18yrs: December 2020, Pressure Area Risk Assessment Chart (Waterlow), Preliminary Pressure Ulcer Risk Assessment (PPURA), Daily repositioning and skin inspection chart, Pressure ulcer grading and excoriation tool, Pressure Ulcer - General wound assessment chart, Scottish Wound Assessment and Action Guide (SWAAG), Scottish Wound Assessment and Action Guide (SWAAG) Quick Reference Guide, Assessment tool for darkly pigmented skin, Scottish Intercollegiate Guidelines Network. Connect with a Smith+Nephew representative to customise the WOUND COMPASS CSA to your formulary today. endobj Home; Prior Authorization (PA) Forms & Related Info; Preferred Drug Lists (PDL) MaineCare PDL; Additional PDL News & Info; Physician Administered Drugs; Drug Utilization Review; Psychiatric Work Group (PWG) Pain Management; Legislation / Policy; Manufacturer Rebate; Experienced Wound Care Providers -PT Physician Important: Only the version of this document available from . Clinicians who are respected leaders and possess command of product usage/costs can serve as clinician champions to lead the change and facilitate the meetings. %%EOF endobj x=r7?[ \RTRm})JbE" `h`8DS h zG?x|_,oWW~{_Wg7bn.vzY5s'_SwV22zXxb&S,.Fgg7+FKAgLcBRRD7 IY4wtg D`X"Q*e\wn]9Pd m~l;gg~O~e_cea{hF]wgA ;xy Kaltostat requires a secondary dressing - a semi-permeable film dressing (e.g. Standard practices versus custom practices that drive costs up. This guide is to aid wound assessment and management, and should How to set up and optimize your wound care formulary PDF Wound Care Formulary Advantage Surgical and Wound Care was established in 2007 by Dr. Robert Marriott and now has grown from a handful of client nursing facilities in Southern California to over 700 across the U.S. today. %PDF-1.7 <>/Metadata 6222 0 R/ViewerPreferences 6223 0 R>> PDF Wound Formulary - GP Portal This wound care formulary companion provides clinical staff with a comprehensive guide to wound dressing products. 2 0 obj As a result, expected dressings outcomes will be achieved, with less product waste. In that way, if you eventually change product brand in that product type, you dont have to obtain a new order. 1: Gastrointestinal System. If you already have an existing formulary, you can replicate it within WoundReference so that you can confirm your products are serving your facility well. We use cookies to provide you with a better service. Advantage Surgical and Wound Care was established in 2007 by Dr. Robert Marriott and now has grown from a handful of client nursing facilities in Southern California to over 700 across the U.S. today. 0000009268 00000 n I"M-'kQ))-RzcQG+%*tt(] J4O{$oM'@Y0ZnI^[ Ra -O84 4 Wirral Community NHS Trust Wound Care July 2020 Alginate Kaltostat is a sterile, non-woven calcium alginate dressing. 0000045321 00000 n 0000004715 00000 n 0000055698 00000 n endobj Implementation 2019 2021 - Aurora Health Care, Welcome to the Long-Term Care Best Practice Spotlight Organization - Information Webinar - RNAO, Teenage Education Payment Guidelines - PSP Learning Hub. Product Available Sizes SKU PECOS Pack Size . No More Tears - Understanding Skin Tears (Part I) | HBOT for Acute Traumatic Ischemia, Crush Injury and Compartment Syndrome - What's New? 0000002102 00000 n 1.1 Dyspepsia and gastro-oesophageal reflux disease (GORD), 1.1.2 Compound alginates and proprietary indigestion preparations, 1.2 Antispasmodics and other drugs altering gut motility, 1.3 Antisecretory drugs and mucosal protectants, 1.5.1.1 Acute Exacerbation of ulcerative colitis, 1.5.1.2 Maintenance of remission of ulcerative colitis, 1.5.2 Corticosteroids inflammatory bowel disease, 1.5.3 Steroid-sparing treatment for inflammatory bowel disease, 1.7 Local preparations for anal and rectal disorders, 1.7.1 Soothing haemorrhoidal preparations, 1.7.2 Compound haemorrhoidal preparations with corticosteroids, 1.9 Drugs affecting intestinal secretions, 2.2.3 Potassium-sparing diuretics and aldosterone antagonists, 2.2.4 Potassium-sparing diuretics with other diuretics, 2.5.2 Centrally acting antihypertensive drugs, 2.5.5 Drugs affecting the renin-angiotensin system, 2.5.5.1 Angiotensin-converting enzyme inhibitors, 2.5.5.2 Angiotensin-II receptor antagonists (AIIRAs/ARBs), 2.6 Nitrates, calcium-channel blockers and other antianginal drugs, 2.6.4 Peripheral vasodilators and related drugs, 2.8.2.2 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent, 2.8.2.3 Prophylaxis of venous thromboembolism in orthopaedics-specialist use in secondary care only, 2.8.2.5 Prevention of Atherothrombotic events, 2.10 Stable angina, acute coronary syndromes and fibrinolysis, 2.11 Antifibrinolytic drugs and haemostatics, 3.1.4 Compound bronchodilator preparations, 3.1.5 Peak flow meters, inhaler devices and nebulisers, 3.2.1 Single agent inhalers [asthma only], 3.2.2 Compound ICS/LABA preparations [asthma], 3.2.3 Compound ICS/LABA preparations COPD, 3.3 Leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors, 3.3.3 Phosphodiesterase type-4 inhibitors, 3.4 Antihistamines, hyposensitisation and allergic emergencies, 3.4.2 Allergen immunotherapy (desensitisation), 4.2 Drugs used in psychoses and related disorders, 4.2.1.1 Management of agitation and aggression, 4.2.3.1 Treatment of the acute phase of mania, 4.2.3.2 Maintenance treatment of bipolar disorder with mood stabilisers, 4.3.1 Mild, moderate and severe depression, 4.3.2 Antidepressants for the treatment of anxiety disorders*, 4.3.2.1 Generalised anxiety disorder (GAD), social anxiety disorder, 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder, 4.4.2 Attention deficit hyperactive disorder (ADHD) in adults, 4.5 Drugs used in the treatment of obesity, 4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract, 4.6.1 Drugs for the short-term treatment of nausea and vomiting, 4.7.4.1 Treatment of acute migraine attack, 4.7.4.3 Drug treatment of cluster headache, 4.9 Drugs used in parkinsonism and related disorders, 4.9.1 Dopaminergic drugs used in parkinsonism, 4.9.1.3 Monoamine-oxidase-B (MAOB) inhibitors, 4.9.1.4 Catechol-O-methyltransferase inhibitors (COMT inhibitors), 4.9.2 Antimuscarinic drugs used in parkinsonism, 4.9.4 Management of dementia in Parkinsons disease, 4.10 Medications used in substance use disorders, 4.10.3 Benzodiazepine and Z drug withdrawal, 4.10.4.3 Interventions for the reduction of alcohol consumption, 4.11.1 Management of Behavioural and Psychological Symptoms of Dementia (BPSD), 6.1.2.3 Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), 6.1.2.5 Sodium-glucose co-transporter 2 (SGLT-2) inhibitors, 6.1.6 Diagnostic and monitoring agents for diabetes mellitus, Summary of oral drug treatments for type 2 diabetes, 6.2 Thyroid and antithyroid drugs and parathyroid disease, 6.4.1.1 Hormone replacement therapy (HRT) for menopausal symptoms, 6.4.1.1a Women who have not had a hysterectomy, 6.4.1.1b Women who have had a hysterectomy or who have a Mirena Intra Uterine System (ISU) in situ, 6.5 Pituitary hormones and anti-oestrogens, 6.5.2 Posterior pituitary hormones and antagonists, 6.5.2.2 Antidiuretic hormone antagonists, 6.6.1 Drugs for the treatment and management of osteoporosis, 6.6.1.3 Other drug therapies used in osteoporosis, 7.0 Contraception, Gynaecology and Urinary Tract Disorders, 7.1.3 Endometriosis (previously diagnosed by laparoscopy), 7.2 Treatment of vaginal and vulval conditions, 7.2.1 Preparations for vaginal and vulval changes, Review copy of Review copy of 7.2.2 Vaginal and vulval infections, 7.3.1 Combined hormonal oral contraceptives, 7.3.2.1 Oral progestogen-only contraceptives, 7.3.2.2 Parenteral progestogen-only contraceptives, 7.3.2.3. While Free Basic members can follow the steps described in this topic to set up and manage their formularies, PRO+HBO and PRO members benefit from full hands-on guidance from our specialists and advisory panel on creation, implementation and maintenance of their digital formularies. <>/Metadata 2891 0 R/ViewerPreferences 2892 0 R>> Evidence based data associated with product usage. The Urology Formulary lists catheters and products recommended for use with catheters which should be used in NHSGGC along with their relevant ordering codes. ?&)]1> qaq\\WP}#s ?4]M5~6(7O[ y+WGE.g*`& PDF Wound Care Formulary Wirral Community NHS Foundation Trust 2020 Wound management items can be provided via ONPOS when a patient is receiving ongoing care from a nurse (or other member of the healthcare team) who is applying the . | Teaching About Chronic Wounds - May, 2021, 2021 Coding & Billing Toolkit for HBOT and Wound Care - March, 2021, Telehealth Evidence and Best Practices | 2021 Reimbursement and Quality Updates - January, 2021, HBOT for diabetic foot ulcers | Wound Care Billing Essentials | Patient-centered Telehealth - December 03, 2020, What's New? Click on the following link to access the Gloucestershire Wound Management Formulary, Includes approved dressings and appliances, Nurse Formulary Order Form: https://ccglive.glos.nhs.uk/intranet/index.php/ccg-strategy/medicines-management/formularies/glos-dressing-formulary. hTYhaVm1Bk4]I(HXT$BAF x >Vz5B]A. If your patients are referred across the continuum of care, try to obtain formularies of the other settings you work with, and consider incorporating product brands they use into your formulary. Budget Review 2021/22 2025/26 - Finance & Performance Scrutiny Panel 5th November 2020, Maternity services principles checklist for the care of pregnant women arriving from Afghanistan. The goal of a wound care product formulary is to help all healthcare professionals who care and treat patients with wounds select the most appropriate dressings and bandages for each patient. M2kV=;G8o'?+zy$ioGuRHHg}Vt=`>Gs9{ bng9,Jusr1i,cSC'G\P'cYXUZG_ #dqc\-MPJ2'[.BMKjK,RAZn[N' Updated results showed a 36% decrease in the number of products utilized by the facility (67 to 43 across 22 types), 38.73% decrease in the monthly average .